Growth & profitability
- Free cash flow has grown 38.4% per year over the past 5 years.
Financial health
- The company holds more cash ($2.8B) than total debt ($430M).
- Operating income covered interest expense -22.5× in the latest year.
OSCR Financials Oscar Health, Inc.
7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $29M | -$443M | 0.0% | -1386.2% | $1.1B | $430M | $2.8B |
| 2024 | $21M | $25M | 0.0% | 278.3% | $950M | $300M | $1.5B |
| 2023 | $21M | -$271M | 0.0% | -1103.4% | -$298M | $299M | $1.9B |
| 2022 | $65M | -$606M | 0.0% | -908.5% | $351M | $298M | $1.6B |
| 2021 | $5M | -$573M | 0.0% | -10094.2% | -$208M | $0 | $1.1B |
| 2020 | $0 | -$407M | — | — | $209M | $142M | $826M |
| 2019 | — | -$261M | — | — | -$191M | — | $337M |
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $6M | $679M | 0.0% | 12313.5% | $2.6B | $431M | $4.8B |
| Dec '25 | $9M | -$353M | 0.0% | -3722.8% | $663M | $430M | $2.8B |
| Sep '25 | $9M | -$137M | 0.0% | -1468.6% | -$974M | $686M | $2.1B |
| Jun '25 | $6M | -$228M | 0.0% | -3547.5% | $500M | $300M | $2.6B |
| Mar '25 | $4M | $275M | 0.0% | 6862.0% | $870M | $300M | $2.2B |
| Dec '24 | $5M | -$154M | 0.0% | -3070.1% | $340M | $300M | $1.5B |
| Sep '24 | $5M | -$55M | 0.0% | -987.4% | -$508M | $299M | $1.2B |
| Jun '24 | $5M | $56M | 0.0% | 1296.3% | $490M | $299M | $2.3B |
| Mar '24 | $6M | $177M | 0.0% | 3293.5% | $628M | $299M | $2.2B |
| Dec '23 | $6M | -$150M | 0.0% | -2541.5% | $291M | $299M | $1.9B |
| Sep '23 | $6M | -$65M | 0.0% | -1051.1% | -$1.2B | $299M | $1.4B |
| Jun '23 | $5M | -$16M | 0.0% | -128.4% | $160M | $298M | $2.3B |
| Mar '23 | $5M | -$40M | 0.0% | -507.0% | $407M | $298M | $2.1B |
| Dec '22 | $3M | -$226M | 0.0% | -8298.4% | $144M | $298M | $1.6B |
| Sep '22 | $19M | -$193M | 0.0% | -990.5% | -$558M | $298M | $2.1B |
| Jun '22 | $20M | -$112M | 0.0% | -520.7% | $208M | $298M | $2.4B |
| Mar '22 | $18M | -$75M | 0.0% | -370.6% | $557M | $297M | $2.1B |
| Dec '21 | $3M | -$199M | 0.0% | -6226.3% | $27M | $0 | $1.1B |
| Sep '21 | $2M | -$211M | 0.0% | -13674.4% | -$595M | $0 | $1.1B |
| Jun '21 | $353000 | -$73M | 0.0% | -20539.9% | $49M | $0 | $1.7B |
Valuation over time
How the market has priced OSCR against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-earnings ratio has risen from 157.5× (Dec '24) to 212.0× (Nov '25).
- The price-to-sales ratio has risen from 30.0× (Mar '23) to 298.9× (Jun '26).
P/E
P/S
Frequently asked questions
Is OSCR growing its revenue and profit?
See the revenue and net-income charts above for Oscar Health, Inc.'s multi-year trend.
How much debt does OSCR have?
As of FY2025, Oscar Health, Inc. reported $430M of total debt against $2.8B of cash; operating income covered interest expense -22.5×.
What is OSCR's profit margin?
In FY2025, gross margin was —, operating margin -1386.2%, and net margin -1549.9%.
What is OSCR's P/E ratio?
As of Jun '26, Oscar Health, Inc. traded at a price-to-earnings ratio of about 212.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.